<SEC-DOCUMENT>0001213900-20-030221-index.html : 20201006
<SEC-HEADER>0001213900-20-030221.hdr.sgml : 20201006
<ACCEPTANCE-DATETIME>20201006104246
ACCESSION NUMBER:		0001213900-20-030221
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20200924
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201006
DATE AS OF CHANGE:		20201006

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Silo Pharma, Inc.
		CENTRAL INDEX KEY:			0001514183
		STANDARD INDUSTRIAL CLASSIFICATION:	APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300]
		IRS NUMBER:				462137136
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54872
		FILM NUMBER:		201225858

	BUSINESS ADDRESS:	
		STREET 1:		1086 TEANECK ROAD
		STREET 2:		SUITE 3A
		CITY:			TEANECK
		STATE:			NJ
		ZIP:			07666
		BUSINESS PHONE:		(718) 400-9031

	MAIL ADDRESS:	
		STREET 1:		1086 TEANECK ROAD
		STREET 2:		SUITE 3A
		CITY:			TEANECK
		STATE:			NJ
		ZIP:			07666

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Uppercut Brands, Inc.
		DATE OF NAME CHANGE:	20190808

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Point Capital, Inc.
		DATE OF NAME CHANGE:	20130130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gold Swap Inc
		DATE OF NAME CHANGE:	20110301
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea127840-8k_silopharma.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea127840-8k_silopharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ea127840ex3-1_silopharma.htm
<DESCRIPTION>CERTIFICATE OF AMENDMENT FILED WITH THE DELAWARE SECRETARY OF STATE ON SEPTEMBER 24, 2020
<TEXT>
Document 2 - file: ea127840ex3-1_silopharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ea127840ex99-1_silopharma.htm
<DESCRIPTION>PRESS RELEASE DATED SEPTEMBER 28, 2020
<TEXT>
Document 3 - file: ea127840ex99-1_silopharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>ea127840ex99-2_silopharma.htm
<DESCRIPTION>PRESS RELEASE DATED OCTOBER 6, 2020
<TEXT>
Document 4 - file: ea127840ex99-2_silopharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex99-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: ex99-2_001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: image_001.jpg

</DOCUMENT>
</SEC-DOCUMENT>